-
Loading metrics
VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics
- Franco Lori,
- Davide De Forni,
- Elly Katabira,
- Denis Baev,
- Renato Maserati,
- Sandra A. Calarota,
- Pedro Cahn,
- Marco Testori,
- Aza Rakhmanova,
- Michael R. Stevens
x
- Published: October 19, 2012
- https://doi.org/10.1371/journal.pone.0047485